ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
2012 · Annals of Oncology · 1,505 citations
https://doi.org/10.1093/annonc/mds236
J
Judith Balmañà
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
593
Papers
18.9K
Citations
66
h-index
184
i10-index
Judith Balmañà is an academic researcher from Hebron University. The author has contributed to research in topics: BRCA gene mutations in cancer & PARP inhibition in cancer therapy & Genetic factors in colorectal cancer. The author has an h-index of 66, co-authored 505 publications.
ORCID: 0000-0002-0762-6415Papers by this author
worksIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
2017 · Nature Genetics · 542 citations
https://doi.org/10.1038/ng.3826
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
2017 · Nature Genetics · 464 citations
https://doi.org/10.1038/ng.3785
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
2013 · PLoS Genetics · 390 citations
https://doi.org/10.1371/journal.pgen.1003212
Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations
2018 · Human Mutation · 305 citations
https://doi.org/10.1002/humu.23406
CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
2016 · Cell Reports · 279 citations
https://doi.org/10.1016/j.celrep.2016.10.077
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat